Can I use your phone? orlistat for sale uk Noting that “there was a trend for dose-dependent increases in overall adverse event rates”, new recruitment and dosing in the ongoing clinical programme was suspended pending further review of the results. Now, following the results from the 608-patient trial, GSK has decided not to continue.